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Abstract
Background: Hereditary sensory and autonomic neuropathies (HSANs) are a group of
genetic disorders affecting the peripheral nervous system. Two different associated vari-
ants have been identified in dogs: 1 in Border Collies and 1 in Spaniels and Pointers.
Objectives: Clinically and genetically characterizeHSAN in a family ofmixed breed dogs.
Animals: Five 7-month-old mixed breed dogs from 2 related litters were presented for
evaluation of a 2-month history of acral mutilation and progressive pelvic limb gait
abnormalities.
Methods: Complete physical, neurological, electrodiagnostic, and histopathological
evaluations were performed. Whole genome sequencing of 2 affected dogs (1 from
each litter) was used to identify variants that were homozygous or heterozygous in
both cases, but wild type in 217 control genomes of 100 breeds. Immunohistochem-
istry was used to assess protein expression.
Results: Complete physical, neurological, electrodiagnostic, and histopathological evalua-
tions confirmed a disorder affecting sensory and autonomic nerves. Whole genome
sequencing identified a missense variant in the RETREG1 (reticulophagy regulator 1) gene
(c.656C > T, p.P219L). All affected dogs were homozygous for the variant, which was
not detected in 1193 dogs from different breeds. Immunohistochemistry showed no
expression of RETREG1 in the cerebellum of affected dogs. One of the affected dogs
lived for 5 years and showed gradual progression of the clinical signs.
Conclusions and Clinical Importance: We confirmed the diagnosis of HSAN in a family
of mixed breed dogs and identified a novel and possibly pathogenic RETREG1 variant.
Affected dogs experienced gradual deterioration over several years.
K E YWORD S
canine, electrodiagnostics, genetics, neurology, peripheral nervous system
Abbreviations: CSF, cerebrospinal fluid; DNA, deoxyribonucleic acid; EDTA, ethylenediaminetetraacetic acid; EMG, electromyography; GDNF, glial cell-derived neurotrophic factor; HSAN,
hereditary sensory and autonomic neuropathy; IBD, identical by descent; OMIA, Online Mendelian Inheritance in Animals; PROVEAN, protein variation effect analyzer; RETREG1, reticulophagy
regulatory 1; RNA, ribonucleic acid; SIFT, sorting intolerant from tolerant; SNAP, sensory nerve action potential; SNV: single nucleotide variants; SSPCA, Scottish Society for Prevention of
Cruelty to Animals; SV, structural variant; WGS, whole genome sequencing.
Received: 24 April 2020 Accepted: 27 July 2021
DOI: 10.1111/jvim.16242
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes.
© 2021 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.
J Vet Intern Med. 2021;1–9. wileyonlinelibrary.com/journal/jvim 1
1 | INTRODUCTION
Hereditary sensory and autonomic neuropathies (HSANs) are a het-
erogeneous group of inherited neurodegenerative diseases affecting
peripheral sensory and autonomic neurons.1-4 Severe distal sensory
loss, acral mutilation, and variable autonomic signs characterize
HSANs.1,4 In humans, 8 forms have been described based on phe-
notype, and genetic variants in more than 20 genes have been
reported.1,4 The pathophysiology of these disorders remains poorly
understood.1-4
Although HSANs have been reported in different dog breeds includ-
ing Border Collie,5-8 Border Collie cross,9 Long-haired Dachshund,10,11
Miniature Pincher,12 Jack Russell Terrier,13 Pointer,14-17 English Springer
Spaniel,17 French Spaniel,17,18 and Fox Terrier,4 only 2 causal variants
have been identified to date. The first is an inversion disrupting RETREG1
(reticulophagy regulator 1), encoding a Golgi protein, in Border Collies and
Border Collie crosses (Online Mendelian Inheritance in Animals [OMIA]
002032-9615).5,9 The second is a point variant in a lincRNA
upstream of the GDNF gene encoding glial cell-derived neuro-
trophic factor in the Pointer, English Springer Spaniel, and French
Spaniel (OMIA 001514-9615).17
Over a 2-year period, 5 mixed breed dog puppies from 2 different
litters were presented to the hospital. All had a history of severe acral
mutilation and progressive pelvic limb gait abnormalities. Here we
describe the clinical presentation, electrodiagnostic findings, histo-
pathological features, and long-term outcome of a novel RETREG1
variant in a family of mixed breed dogs.
2 | MATERIALS AND METHODS
2.1 | Animals
Five related mixed breed dogs were evaluated separately, each at the
age of approximately 7 months (Figure 1A). They were from 2 different
litters from the same reportedly healthy dam; 1 litter consisting of
2 females was born in December 2009 (2009 litter) and the other con-
sisting of 3 males was born in December 2010 (2010 litter), but no
other parentage information was available. These puppies had been
relinquished to the Scottish Society for Prevention of Cruelty to Ani-
mals (SSPCA) because they were visibly not healthy. We do not know if
there were healthy littermates in addition to the 5 affected dogs. Resid-
ual blood samples in ethylenediaminetetraacetic acid (EDTA) were
retained from 4 dogs for genetic investigations. Samples could not be
obtained from the dam or sire(s). Additional diagnostic tests were per-
formed on 2 dogs (2009 litter), including blood testing and cerebrospi-
nal fluid (CSF) analysis, and urinalysis in 1 dog.
2.2 | Electrodiagnostic testing
Two affected puppies (2009 litter) were anesthetized to perform a
complete electrodiagnostic examination including electromyography
(EMG) and measurement of mean motor and sensory nerve conduc-
tion velocities (Medelec Synergy, Viasys Healthcare, Old Woking, UK).
Insulated stainless steel needle electrodes were used for nerve stimu-
lation, muscle recording, and ground. Motor nerve conduction veloci-
ties of the peroneal and ulnar nerves were calculated, and sensory
nerve conduction studies were performed on the peroneal and ulnar
nerves as previously described.19-21
2.3 | Histopathology and immunohistochemistry
Owner consent was given at presentation for euthanasia and complete
necropsy in 3 of the affected dogs (2010 litter). The other 2 dogs (2009
litter) had muscle (gastrocnemius and biceps femoris) and nerve (com-
mon peroneal) biopsy samples taken under general anesthesia. In addi-
tion to routine samples taken during necropsy (including brain, cervical,
thoracic, and lumbar spinal cord), representative samples from multiple
nerves (sciatic, common peroneal, ulnar, radial, cutaneous sural, and
vagosympathetic nerve trunk), dorsal root ganglia (cervical, thoracic,
and lumbar), and autonomic ganglia were collected and fixed in 10%
buffered formalin. Slices of formalin-fixed samples were embedded in
paraffin before stainingwith hematoxylin and eosin and luxol fast blue.
Immunohistochemistry for RETREG1 protein was performed using a
commercially available RETREG1 polyclonal antibody (RETREG1 poly-
clonal antibody [PA5-42647], ThermoFisher Scientific, Waltham, Massa-
chusetts). Antibody dilution was 1:200 and antigen retrieval using pH 8
EDTA buffer was employed.22 Paraffin blocks containing cerebellum
from 3 affected dogs and 2 dogs of similar age from archived samples
(normal controls) were stained. Cerebellum was used because it was the
central nervous system tissue available for affected and control cases.
2.4 | Sequencing and genotyping
Deoxyribonucleic acid from the affected animals (n = 3) was success-
fully extracted from residual EDTA blood using a DNeasy Blood and
Tissue kit (Qiagen, Crawley, UK). Whole genome sequencing (WGS) of
2 affected dogs, 1 from each litter, was outsourced to Edinburgh
Genomics, UK; a TruSeq Nano DNA Library (Illumina) was sequenced
using the Illumina HiSeq X platform, generating 150 bp paired-end
reads and at least 30X coverage. Data analysis was performed using
standard freely available software. Sequence reads were aligned to
the dog genome reference (CanFam3.1) using Burrows-Wheeler
Aligner (BWA) and variants were called using Genome Analysis Toolkit
(GATK) using GATK best practices.23,24 Genomes are available from
the European Nucleotide Archive (Accession no. PRJEB39868).
Samples of DNA from the affected dogs used for WGS (1 case
from each litter) also were submitted for a commercially available dog
breed ancestry test (Wisdom Panel, Mars Veterinary, Vancouver,
Washington) to determine breed composition and relatedness of the
affected dogs. Specific breeds identified were designated “ancestral
breeds.” To assess relatedness, windows comprising approximately
20 markers and encompassing 1877 markers in total were compared
2 GUTIERREZ-QUINTANA ET AL.
between the 2 cases, to determine the proportion of windows that
shared both haplotypes or 1 haplotype, identical by descent (IBD),
IBD2, and IBD1, respectively (personal communication, Stephen
Davison).
Initially, existing WGS data obtained for other studies from
217 dogs of 100 breeds and crossbreeds were used as controls for
the genetic analysis, including 8 Border Collies, 6 Labrador Retrievers,
and 1 German Shepherd (the “ancestral breeds”). Two sets of analyses
were conducted, based on an autosomal recessive or autosomal domi-
nant mode of inheritance. For autosomal recessive inheritance, vari-
ants that were homozygous in both cases, heterozygous or homozygous
for the reference allele in the 15 “ancestral” genomes, and homozygous
for the reference allele in remaining 202 genomes were retained for fur-
ther investigation. For autosomal dominant inheritance, variants that
were homozygous or heterozygous in both cases and homozygous for
the reference allele in all 217 other genomes were retained for further
F IGURE 1 A. Pedigree of the affected family. Five affected dogs (filled symbols) were born to the same dam; 3 males in 1 litter and 2 females
in a separate litter. The identity of the sires of both litters is unknown, but relationship testing shows they are likely to be the same dog. One
affected dog from each litter was whole genome sequenced (red symbols) and DNA samples were obtained from a further 2 dogs (blue symbols).
Three of the cases were genotyped homozygous for the RETREG1 variant (T/T) and DNA from 1 case never yielded any successful genotyping
results (‡). Males are denoted by square symbols and females by circles. This pedigree may be incomplete (†)—the existence of healthy littermates
is unknown. B. Whole genome sequence viewed with Integrative Genomics Viewer (IGV). Both affected dogs were homozygous for the variant
(T) allele and an unaffected dog was homozygous for the wild type (C) allele. The variant is in exon 6 of RETREG1 and alters the amino acid from a
Proline (P) to a Leucine (L). C. The RETREG1 C > T variant was confirmed by Sanger sequencing in all 3 affected dogs
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investigation. These retained candidate variants also were screened in
dog genomes from 616 genomes: 598 dogs (excluding 32 dogs also in
the initial analysis) of 121 breeds, 10 mixed breed dogs, and 8 wolves
from the Dog Biomedical Variant Database Consortium (DBVDC)25 to
assess their frequency. In addition, all annotated genes (ie, genes anno-
tated with a gene symbol, but not genes annotated with only an
ENSCAF ID number) in which these retained variants were found were
prioritized for further investigation using the VarElect NGS Phenotyper
(https://ve.genecards.org/#input) and based on the keywords “sensory
autonomic neuropathy,” “auto-mutilation,” “sensory ganglion,” “auto-
nomic ganglion,” “insensitivity to pain,” and “joint deformity.”26 In paral-
lel, variants segregating with an autosomal recessive mode of inheritance
and predicted to change a protein also were investigated further.
Remaining candidate variants then were validated by Sanger
Sequencing in 3 cases (2 of which had already undergone WGS) and
2 unrelated, unaffected dogs (1 Large Munsterlander and 1 Alaskan
Malamute). The following sequencing primers were used: RETREG1:
GTTGATTTGGTGGCAGGTCTT, ATAAAGAGCCAGCTGACGTCT; KL
RG2: TCAGGAAGATTTGGAAGCCTA, TTCCTGAGCAGATACCCAG
TC; MUC19: GACCCACCATTCTTGAGTCAC, AGCAGAGGATCCATTT
CAAAG. In addition, RETREG1 was manually interrogated for struc-
tural variants (SVs) using Integrative Genomics Viewer (IGV).27 Finally,
the RETREG1 candidate variant was genotyped in 360 dogs from
122 breeds by TaqMan assay (primers: CCCACACTCCTCCCTTCTT
AT, GCAGAACTGACTTGATTTTGCT; wild type probe: 506-FAM-A
CACTTAAACAGTGGACACAAAAATGCAC, variant probe: 50HEX-
ACACTTAAACAGTAGACACAAAAATGCAC). Primers and probes
were designed using Primer3 (http://bioinfo.ut.ee/primer3-0.4.0/)
and obtained from Integrated DNA Technologies (IDT, Leuven,
Belgium).28
The protein amino acid change caused by the candidate variant was
assessed using multiple in silico prediction tools: SIFT, Polyphen-2,
PROVEAN, MutPred2, and SNPs & Go.29-33 The Genome Aggregation
Database (gnomAD) also was interrogated to assess the frequency of
F IGURE 2 Photos of affected dogs. A and B demonstrate the hyperextension of the tarsi and knuckling when standing. C, D, and E
demonstrate different severity of lesions in the pelvic limb digits secondary to acral mutilation
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variants at human loci that are the equivalent of candidate variants.34
Canine gene and protein annotations are based on the reference genome
CanFam3.1, reference sequence NC_006586 (chromosome 4 of Can-
Fam3.1), gene NM_001314111.1 (RETREG1). Human gene and protein
annotations are based on reference sequence NC_000005.9
(Chromosome 5, genome build GRCh37.p13) and NP_001030022.1
(RETREG1 isoform 1).
3 | RESULTS
3.1 | Clinical description
Five related mixed breed puppies from 2 litters were presented over a
2-year period to the Small Animal Hospital of the University of Glas-
gow. All had a previous history of severe mutilation of the distal pelvic
limbs and chronic progressive pelvic limb gait abnormalities. In all
dogs, physical examination findings included multiple areas of trauma
on the distal aspect of both pelvic limbs (mainly digits) with some of
the dogs having had surgical digit amputations before referral
(Figure 2). Neurological examination identified normal mentation and
cranial nerve function. Gait assessment identified severe propriocep-
tive ataxia in all limbs with the pelvic limbs more severely affected,
including occasional knuckling of the pelvic limb paws and hyperex-
tension of both tarsi (Figure 2). Paw positioning and hopping were
decreased to absent in the pelvic limbs and normal in the thoracic
limbs. Withdrawal reflex was decreased and patellar reflex increased
in both pelvic limbs, but perineal and cutaneous trunci reflexes were
intact. Superficial and deep pain perception was absent distal to the
carpi and tarsi but present proximally, and in the tail, trunk, and head
(as illustrated in Video S1). Findings were consistent with peripheral
sensory neuropathy.
F IGURE 3 Microscopic (hematoxylin and eosin, 100 magnification) section of a dorsal nerve root ganglion of a normal dog (A) and an
affected dog (B). There are reduced numbers of neurons and the presence of neuronal degeneration (asterisk). Microscopic sections of the
granular cell layer of the cerebellum (immunohistochemistry RETREG1 antibody, 110 magnification) of a normal dog (C) and an affected dog (D).
There is a lack of expression of RETREG1 (brown pigment) in the affected dog
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Complete blood cell count and serum biochemistry results were
normal in all cases. Lumbar puncture for CSF collection was per-
formed in 2 cases (2009 litter) and nucleated cell count and protein
concentration were normal. Serology testing for Toxoplasma gondii
and Neospora caninum was performed in the same 2 dogs and was
negative. A urine sample was collected by cystocentesis from 1 dog
and had normal organic acid concentrations.
3.2 | Electrodiagnostic testing
Electrodiagnostic testing was performed in the same 2 dogs, and
abnormalities were limited to the absence of sensory nerve action
potentials (SNAP) during sensory nerve stimulation.
3.3 | Histopathology
No macroscopic changes were observed. Histopathological abnormalities
were limited to the peripheral nerves, dorsal root ganglia, and autonomic
ganglia. Nerve histology indicatedmoderatemyelinated fiber loss and axo-
nal features compatible with Wallerian degeneration with some dystro-
phic changes. These changes were more severe in purely sensory nerves
(cutaneous sural nerve) and autonomic nerves (vagus) than in mixed
nerves (motor and sensory). Dorsal root ganglia and autonomic ganglia
(cervical, celiac, andmesenteric) hadmoderate to severe neuronal necrosis
and degeneration with moderate infiltration of lymphocytes and plasma
cells (Figure 3A,B). No changeswere observed in themuscles sampled.
3.4 | Follow-up
Three dogs were euthanized at presentation (2010 litter). Two dogs
(2009 litter) were managed with protective collars and bandages to pre-
vent further self-mutilation. They both received a 2-month course of
gabapentin (10 mg/kg PO q8h; Gabapentin 100 mg capsules, Actavis
Ltd, Dublin, Ireland, UK) with no clinically relevant improvement. Slow
deterioration in the gait was observed in both cases with gradual
involvement of the thoracic limbs. One dog was euthanized at 2 years
of age because of urinary incontinence. The other dog was euthanized
at 5 years of age when it developed megaesophagus (confirmed radio-
graphically) and secondary aspiration pneumonia. At this time, marked
proprioceptive ataxia was present in all limbs and persistent knuckling
of both pelvic limbs with secondary malformation was observed in both
tarsi. No superficial or deep pain perception in the distal or proximal
portion of the limbs could be detected (as illustrated in Video S2).
3.5 | Sequencing, genotyping, and protein
expression
Because of incomplete availability of pedigree information, pedigree
analysis could not be used to determine the mode of inheritance.
However, comparison of the Wisdom Panel data between the 2 cases
showed that 17% of windows were IBD2 (the 2 cases had identical
haplotypes on both chromosomes) and 66% were IBD1 (the 2 cases
had identical haplotypes on 1 chromosome). This finding is consistent
with the IBD expected between full siblings, suggesting the 2 affected
litters share the same sire and dam. Alternatively, it is possible there
are 2 different sires that are closely related to each other, or that the
sire(s) are closely related to the dam. In addition, both males and
females were affected, and 2 separate litters were affected, but the
female dam was not affected. Taken together, these findings suggest
an autosomal recessive mode of inheritance is more likely, although
we cannot exclude the possibility of some other mode of inheritance.
Variants identified in the 2 affected genomes were filtered first based
on autosomal recessive segregation and next on autosomal dominant
segregation. There were 570 variants that met the recessive segrega-
tion criteria and 12 026 that met the dominant segregation criteria
described in the methods, of which 435 met both recessive and domi-
nant criteria.
All of the annotated genes (excluding genes only annotated with
ENSCAF IDs) implicated among the recessive variants (137 variants in
73 genes) and dominant variants (3887 variants in 1706 genes) were
analyzed using the VarElect online tool and the phenotype keywords
provided in the methods. Only 1 of the recessive genes was a direct
match (RETREG1) and 38 of the dominant genes were a direct match,
although 2 (RETREG1 and WNK1) had much higher scores (11.09 and
11.19 respectively) than the remainder (≤2.88). The keywords “sen-
sory autonomic neuropathy” and “insensitivity to pain” matched phe-
notypes associated with both RETREG1 and WNK1, making any
variants in these genes promising candidate variants. Only 1 variant
(CFA4:86916562, C > T), in the RETREG1 gene, was shared between
the recessive and dominant lists of variants and is predicted to be a
missense variant, located in exon 6 of RETREG1. Similarly, only 1 vari-
ant (CFA27:42850851) was in the WNK1 gene, although it is intronic
and approximately 6670 nucleotides away from the nearest exon. On
closer examination, this variant is 1 of 5 alleles of a trinucleotide
(GTT) repeat element (microsatellite) represented among the
219 WGS. The predominant allele “a” (335/436 alleles) contains
10 GTT repeats, allele “b” (25/436 alleles) contains 11 repeats, allele
“c” (71/436 alleles) contains 12 repeats, allele “d” (3/436 alleles) con-
tains 13 repeats, and allele “e” (2/436 alleles) contains 14 repeats.
The 2 cases both have the genotype a/e. This finding is consistent
with a polymorphic, but benign, microsatellite marker, and this WNK1
variant therefore was excluded from further examination. RETREG1
was reported previously to cause sensory neuropathy in dogs5,9 and
humans.31 The variant in RETREG1 therefore remains the strongest
candidate variant and was retained for further investigation.
In addition to analyzing variants in candidate genes as indicated
by VarElect, we also focused on homozygous autosomal recessive var-
iants predicted to alter a protein, of which there were 4. A missense
variant in the gene CAST also was observed in 2/616 DBVDC
genomes (1 homozygous and 1 heterozygous Labrador Retriever, 1 of
these was of German ancestry, was submitted for research at the age
of 14 months with skeletal dysplasia type 2 (SD2) and was 1 of the
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cases previously reported.35 There was no report of sensory neuropa-
thy at the time of sample submission (personal communication, Tosso
Leeb); further clinical information about the second dog was
unavailable (personal communication, Oliver Forman) and was there-
fore excluded as likely benign. The remaining 3 variants were absent
from all 616 DBVDC genomes. One variant (CFA3:1083274, G > A)
initially was thought to be in a gene homologous to human KLRG2,
but the canine Ensembl gene (ENSCAFG00000031165) has since
been retired and the variant is now considered intergenic. The second
variant (CFA27:13231303, C > G) was in a gene orthologous to
MUC19 and the third was the same variant in the RETREG1 gene iden-
tified through the VarElect workflow. The intergenic/KLRG2 variant
was found to be heterozygous in 1 of the cases by Sanger sequencing
and (because KLRG2 has not been associated with any disorders to
our knowledge) it, therefore, was considered benign and excluded
from further investigation. The MUC19 and RETREG1 variants were
homozygous in all 3 cases by Sanger sequencing, and homozygous for
the wild type allele in 2 control dogs. However, MUC19 (Mucin
19, oligomeric) encodes a member of the gel-forming mucin protein
family, responsible for the gel-like properties of mucus. MUC19 is
expressed primarily in salivary glands and testes, and this variant
therefore was considered benign. Finally, the RETREG1 variant was
retained and prioritized for further investigation because of its previ-
ous association with sensory neuropathy. Multiple attempts at ampli-
fying DNA to screen these 3 variants from the fourth case (Figure 1A)
were unsuccessful.
Comparison of the CanFam3.1 RETREG1 annotation (NM_0013
14111.1) with the human RETREG1 annotation (NP_001030022.1) indi-
cated similar structure of 9 exons, very similar amino acid sequence with a
difference in the number of amino acid residues: 497 in humans and
485 in dogs. The observed missense variant in RETREG1 is a C > T variant
at position 656 of the coding sequence in exon 6 (c.656C > T, p.P219L;
Figure 1) and is predicted to be deleterious by all prediction algorithms
used (Table S1). This variant alsowas not found in 360 dogs of 120 breeds,
making it absent from a total of 1193 canids (1175 dogs of 192 breeds,
10mixed breed dogs, and 8wolves). This variant is different from the RET-
REG1 variant reported in Border Collies. The ancestry test (Figure S1) indi-
cated that 1 of the parents of both litters was 25%German Shepherd and
25% Parson Russell Terrier. Border Collie also was detected in the same
parent for 1 puppy and Labrador Retriever was detected in the other par-
ent for the other puppy, but both with low confidence. All 4 of these
breeds were represented among the 1193 dogs homozygous for the wild
type allele (3 Parson Russell Terriers, 23 German Shepherds, 48 Border
Collies, and 20 Labrador Retrievers).
The amino acid affected (P219 in the dog and P231 in humans) is con-
served in 94 species. The equivalent human nucleotide (5:16479075 in
GRCh37) is not represented at all in the gnomAD dataset, although P231
is represented. Three variants are observed in only 1 or 2 individuals each
(of almost 250 000) and in the heterozygous state only (Table S2).
Immunohistochemistry for RETREG1 showed normal expression in
the cerebellum of 2 control dogs and no expression in the cerebellum
of 3 of the affected dogs (Figure 3C,D). We therefore concluded that
the c.656C > T, p.P219L RETREG1 variant is likely pathogenic.
4 | DISCUSSION
We confirmed a HSAN in a family of mixed breed dogs and identified
a novel variant in the canine RETREG1 gene. Our study had some limi-
tations that warrant further discussion. First, because of the lack of
pedigree and phenotypic data for relatives, we cannot exclude the
possibility that the mode of inheritance may be autosomal dominant
or some other more complex form of inheritance, such as dominant with
incomplete penetrance or polygenic/complex. However, the finding that
the 2009 litter and 2010 litter are likely full siblings adds support to the
hypothesis of autosomal recessive inheritance. Second, because we did
not look for structural variants (SVs) on a genome-wide level we cannot
exclude the possibility that the disease is caused by a SV. However,
because SVs are usually in linkage disequilibrium with single nucleotide
variants (SNV) and all SNVs in or near functional candidate genes were
examined (using VarElect), this possibility is unlikely. Third, we cannot
exclude the possibility that 1 of the variants designated as intergenic or
in or near an ENSCAF annotated gene is causal. Finally, because we have
not genotyped large numbers of dogs of the ancestral breeds, we cannot
exclude the possibility that the variant is in fact a rare but benign variant
that segregates in 1 of these breeds. We confirmed that the amino acid
affected (P219 in the dog and P231 in humans) is conserved in 94 spe-
cies, the equivalent human nucleotide is not represented at all in the
gnomAD dataset, and amino acid changes at P231 are rare and heterozy-
gous only. These findings suggest that variants at this locus are more
likely to be pathogenic. Taken with the observation that RETREG1 pro-
tein expression is absent in the affected dogs, this finding suggests that
RETREG1 is likely the gene causing disease. However, we still cannot
exclude the possibility that the RETREG1 variant is not causal but is
rather in linkage disequilibrium with the causal variant, or simply happens
to segregate with the disease by chance.
The protein encoded by RETREG1 is responsible for regulating
turnover of the endoplasmic reticulum by selective phagocytosis.36,37
Its inhibition impairs proteostasis in the endoplasmic reticulum because
of accumulation of misfolded proteins, which in turn compromises neu-
ronal survival and causes neurodegeneration.36,37 The mechanism by
which only sensory and autonomic neurons are affected remains
unknown, because the RETREG1 protein is expressed in many other
neurons and the changes do not seem to cause histopathological abnor-
malities (as in the cerebellum used for immunohistochemistry in our
study).36 Human P231 is in the fourth transmembrane domain and in a
reticulon homology domain (RHD) of the RETREG1.38 Proline residues
within transmembrane domains cause kinks in the alpha helices, which in
turn affects the structure of the protein.39 The structure and topology of
the RHD of RETREG1 affect the ability of the protein to sense and
induce endoplasmic reticulum curvature during autophagy.38 It therefore
follows that a possible effect of the variant described here is a change in
the structure of the protein, which in turn could be affecting normal and
healthy autophagy. Deregulation of autophagy is a feature of various
neurodegenerative diseases in humans.40
This variant is the second reported in RETREG1 that is associated
with HSAN in dogs. Previously, an inversion disrupting this gene was
described in Border Collies and in mixed breed dogs with Border
GUTIERREZ-QUINTANA ET AL. 7
Collie ancestry.5,9 Interestingly, there are strong similarities in some of
the clinical signs between the previously reported Border Collies and
the cases presented here, including similar age of onset, the pelvic
limbs being more severely affected than the thoracic limbs, and the
presence of self-mutilation and absent nociception in the distal por-
tion of the limbs.5-9 There are also some differences, with the primary
difference being that none of the dogs described here experienced
autonomic signs until later in life, whereas some of the previously
reported Border Collies had urinary incontinence from a young age.
Also, some of the previously reported Border Collies had decreased
motor nerve conduction velocities, a feature not observed in the
2 dogs in our report that had electrodiagnostic studies performed.5-9
Long-term outcome has only been reported in the literature in
1 of the Border Collies that lived for almost 2 years, and the affected
dog developed severe regurgitation and marked muscle atrophy.8 The
2 dogs with long-term outcome in our study developed gradual deteri-
oration of the proprioceptive ataxia, malformation of both tarsi, and
developed autonomic signs (urinary incontinence at 2 years of age in
1 dog and megaesophagus in another dog at 5 years of age), but no
signs of motor involvement or muscle atrophy. Interestingly, 1 of the
dogs lived for 5 years, which could indicate that this family of mixed
breed dogs had a less severe form of the disease than the Border Col-
lies, but it is difficult to be certain because of the low number of long-
term outcomes reported. The autonomic deficits appeared to take
longer to develop than did the sensory deficits in our cases.
Although HSANs have been reported in different dog breeds,
they remain rare. The forms of HSAN reported in the long-haired
Dachshund,10,11 Jack Russell Terrier13 and in Border Collies have
more similarities to that reported here because they all presented with
proprioceptive deficits and signs of autonomic dysfunction. This find-
ing is in contrast to HSANs reported in the Miniature Pincher,12
Pointer,14-17 English Springer Spaniel,17 French Spaniel,17,18 and Fox
Terrier,4 which present with loss of pain sensation, but no propriocep-
tive deficits or autonomic signs. Recently, a variant in the GDNF gene
was reported as the cause of insensitivity to pain in the Pointer,
English Springer Spaniel, and French Spaniel.17
Histopathologically, the severity of changes was variable depending
on the nerve and ganglion analyzed with purely sensory nerves being
more affected than mixed (motor and sensory) and autonomic nerves,
and sensory ganglia showing more severe changes than autonomic gang-
lia. The presence of lymphoplasmocytic infiltrates in some of the ganglia
was surprising, but inflammation has been described in some hereditary
neuropathies in humans.36 The lack of expression of RETREG1 on immu-
nohistochemistry in the affected dogs suggests that the amino acid
change affects protein conformation and antibody binding.
In humans, a growing number of HSANs have been assigned to
associated gene defects in recent years.1,2,4 A variant in RETREG1 was
first reported in 2009 as the cause of severe sensory and autonomic
neuropathy in a Saudi-Arabian family.36 Several neuropathy genes
have been identified so far, with some involved in cytoskeleton for-
mation, transcriptional regulation, intracellular transport, endoplasmic
reticulum function, sphingolipid biosynthesis, and interaction with the
extracellular environment.1,2 This variety of genes illustrates how
many different components are required for building and maintaining
the peripheral nervous system and the fact that the central and
peripheral nervous systems are particularly vulnerable to dysfunctions
in multiple pathways.2 Despite approximately 20 genes having been
implicated in HSAN in humans, some cases remain unexplained and
the availability of spontaneous models such as the dog can help
explain the pathophysiology of these diseases.4
To our knowledge, our study is the second description of
HSAN associated with a RETREG1 variant in dogs. The identity of
the sire(s) of the 2 litters is unknown, but analysis of Wisdom Panel
data supports the hypothesis that they are likely to be the same
dog, could be closely related to the dam, or could be related to each
other (if not a single sire). It is not currently known whether the
causal variant arose de novo in the recent ancestry of the affected
dogs described in our study or whether it arose more distantly, in
which case the possibility exists it is segregating in the wider canine
population. The affected dogs were crossbred, but do have German
Shepherd, Parson Russell Terrier, and possibly also Labrador
Retriever and Border Collie in their recent ancestry. The variant
was not detected in these breeds during our study, but the number
of dogs tested was small. Future studies of these breeds searching
for the RETREG1 variant described here should be considered. With
good management (use of a protective collar and bandages to pre-
vent self-mutilation), some affected dogs can have a longer lifespan
than previously reported in the Border Collie despite gradual dete-
rioration and later appearance of autonomic signs.
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